SB392 Summary

• Creates a program authorizing non-medical personnel to stock and administer epinephrine auto-injectors at authorized entities (recreation camps, colleges, restaurants, sports venues, etc.) where anaphylaxis-causing allergens may be present.

• Requires trained employees or agents to complete initial anaphylaxis training and recertification every two years covering recognition of severe allergic reactions, storage and administration procedures, and emergency follow-up.

• Allows medical practitioners to prescribe epinephrine auto-injectors in an authorized entity's name with two-year validity, and permits employees to provide or administer injectors to individuals in good faith believed to be experiencing anaphylaxis regardless of prior diagnosis.

• Establishes Emergency Public Access Stations (EPAS) as locked containers storing epinephrine auto-injectors under medical practitioner oversight, accessible to lay rescuers who consult with a health professional in real time before use.

• Provides liability immunity from injuries resulting from dispensing or administering epinephrine auto-injectors, except for unreasonable, reckless, gross, willful, or wanton negligence, and authorizes the Department of Public Health to promulgate implementing rules.